AbbVie starts construction on $70M R&D, manufacturing center expansion

[Groundbreaking]
oranhall/iStock via Getty Images

* AbbVie (NYSE:ABBV [https://seekingalpha.com/symbol/ABBV]) has broken ground on a $70M expansion of an existing site in Worcester, Mass., that serves as a biologics R&D center and manufacturing facility.
* The company said the additional space will boost [https://seekingalpha.com/pr/20249833-abbvie-begins-construction-on-70-million-expansion-to-further-increase-biologics]its biologics manufacturing capacity. The plan also calls for a three-story building for laboratory, warehouse, and office space. Also, the new facilities will speed up the transfer of some oncology therapies from Europe to the U.S.
* During its Q1 earnings call in late April, AbbVie management said it would invest $10B [https://seekingalpha.com/article/4778379-abbvie-first-quarter-beat-and-raise-leaves-room-for-more] to improve its supply chain in the US.

MORE ON ABBVIE

* AbbVie For Healthy Dividend Growth [https://seekingalpha.com/article/4826365-abbvie-for-healthy-dividend-growth]
* AbbVie: Best Time To Sell In 5 Years (Rating Downgrade) [https://seekingalpha.com/article/4823412-abbvie-best-time-to-sell-in-5-years-rating-downgrade]
* AbbVie Inc. (ABBV) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript) [https://seekingalpha.com/article/4821025-abbvie-inc-abbv-presents-at-morgan-stanley-23rd-annual-global-healthcare-conference]
* AbbVie launching ovarian cancer therapy Elahere in UK at US list price [https://seekingalpha.com/news/4499907-abbvie-launching-ovarian-cancer-therapy-elahere-uk-at-us-list-price]
* SA analyst upgrades/downgrades: AMD, SNOW, MU, and ABBV [https://seekingalpha.com/news/4495738-sa-analyst-upgradesdowngrades-amd-snow-mu-and-abbv]